Back to PE Pentwater Capital Management LP
BHVNShowing 0 of 3 quarters
Position history for PEPentwater Capital Management LP's holdings in BIOHAVEN PHARMACEUTICAL HOLD
As of its Q3 2022 13F, Pentwater Capital Management held 1,163,000 shares of BHVN (Biohaven Pharmaceutical Hold), worth $175.8M. Pentwater Capital Management's 13F filings listed BHVN from Q2 2022 to Q3 2022, 2 quarterly filings. BHVN was 2.0% of Pentwater Capital Management's reported 13F portfolio.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of BHVN: Capital World Investors, Capital International Investors